Skip to main content
UBCARE CO., LTD. logo

UBCARE CO., LTD. — Investor Relations & Filings

Ticker · 032620 ISIN · KR7032620007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 263 across all filing types
Latest filing 2024-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 032620

About UBCARE CO., LTD.

https://www.ubcare.co.kr/

UBCARE CO., LTD. is a healthcare solutions provider specializing in the development and supply of digital healthcare technology. The company's core business revolves around its Electronic Medical Record (EMR) systems, which are designed for use in hospitals, clinics, and pharmacies. In addition to its EMR solutions, UBCARE operates in the pharmaceutical e-commerce and distribution sector, offering platforms that facilitate the procurement and circulation of medical supplies and pharmaceuticals for healthcare providers.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company Ubicare. It provides a summary of the audit opinion (which is 'Appropriate' or 'Unqualified'), key financial data (assets, liabilities, equity, revenue, profit/loss), and details regarding the auditor (Samjong KPMG). While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report to the regulator, rather than the full annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2023
2024-03-19 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system (KIND) regarding a correction (amendment) to a previously filed financial disclosure ('매출액 또는 손익구조 30% 이상 변동'). It details specific changes to financial figures (liabilities and equity) due to an external audit process. Since it is a formal regulatory disclosure of financial performance changes and does not fit into specific categories like 10-K or IR (which are comprehensive reports), it is classified as a general regulatory filing. FY 2023
2024-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Ubcare Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and financial statements. This type of document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming AGM and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-12 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Ubicare. It outlines the date, location, and agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-03-08 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for Holding a General Meeting on a Concentrated Date'. It explains why the company (Ubicare) is holding its shareholder meeting on a date that coincides with other companies' meetings, citing internal audit and reporting schedules. This is a specific regulatory disclosure requirement in the Korean market and does not fit into categories like AGM-R (presentation materials) or PSI (proxy solicitation). As it is a regulatory disclosure regarding corporate governance scheduling, it falls under the RNS (Regulatory Filings) category.
2024-03-08 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing from Ubicare regarding the 'Convocation of the General Meeting of Shareholders' (주주총회소집결의). It details the agenda for the upcoming annual general meeting, including the appointment of directors, approval of financial statements, and dividend proposals. While it contains information about board appointments, it is primarily a notice for the shareholder meeting, which falls under Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on the proposed agenda items.
2024-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.